Approval · Notice of Compliance 35159 · 2025
OPFOLDA: Notice of Compliance 35159
Issued April 10, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35159
- Date
- April 10, 2025
- Company
- Amicus Therapeutics Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPFOLDA | 02556812 | Marketed |
Medicinal ingredients
- MIGLUSTAT 65 MG per CAP